Ficha del valor · trimestre archivado
VRDN
Viridian Therapeutics, Inc. · Healthcare · Biotechnology
16Tenedores rastreados
-1Δ titulares
34.97MAcciones mantenidas
$754.70MValor declarado
+0Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables):
amplitud de titulares -5.9% ·
flujo de acciones -0.1% ·
nuevas posiciones netas -6.2%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -12 | 71.65M | $1.32B | +6 | −18 |
| Q1 2026 | 88 | +7 | 66.96M | $1.32B | +11 | −5 |
| Q4 2025 | 82 | +2 | 62.58M | $1.95B | +4 | −1 |
| Q3 2025 | 16 | -1 | 34.97M | $754.70M | — | −1 |
| Q2 2025 | 14 | -2 | 33.44M | $467.46M | — | −2 |
| Q1 2025 | 13 | +2 | 10.47M | $141.20M | +2 | — |
| Q4 2024 | 11 | -2 | 10.88M | $208.63M | — | −2 |
| Q3 2024 | 12 | +3 | 5.78M | $131.57M | +3 | — |
| Q2 2024 | 9 | — | 3.15M | $40.97M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (pasivo) | 2.55M | 0.0% | $55.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 2.42M | -16.5% | $52.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 2.42M | -16.5% | $52.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasivo) | 1.77M | +1.5% | $38.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasivo) | 1.77M | +1.5% | $38.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 1.22M | +10.1% | $26.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 1.20M | +135.6% | $25.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | Marshall Wace ✦ | 869.19K | -28.0% | $18.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 764.56K | — | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 764.56K | — | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Millennium Management ✦ | 136.28K | +129.3% | $2.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 52 | Citadel Advisors ✦ | 77.37K | -88.1% | $1.67M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | Two Sigma Investments ✦ | 22.01K | -68.5% | $474,997 | 0.0% | ▼ Trim | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $1.45M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 225 tenedores, 111.32M acciones, $2.12B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Aug 19
Tousignant Jennifer
Officer · 4.21K acc. · $103,194
Aug 19
Tousignant Jennifer
Officer · 10.00K acc. · $245,000
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
Aug 20
SC 13G — Point72 Asset Management, L.P.
Aug 14
SC 13G/A — Paradigm Biocapital Advisors LP
Aug 14
SC 13G/A — Kynam Capital Management, LP
Aug 14
SC 13G/A — Deep Track Capital, LP
Aug 14
SC 13G — PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G — STATE STREET CORP
Jun 26
SC 13G — Paradigm Biocapital Advisors LP
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API